Application of Free Energy Perturbation for the Design of BACE1 Inhibitors

被引:88
|
作者
Ciordia, Myriam [1 ,2 ]
Perez-Benito, Laura [1 ,3 ]
Delgado, Francisca [1 ]
Trabanco, Andres A. [1 ]
Tresadern, Gary [1 ]
机构
[1] Janssen Res & Dev, C Jarama 75A, Toledo 45007, Spain
[2] Univ CEU San Pablo, Fac Farm, Dept Quim & Bioquim, Urbanizac Monteprincipe Ctra, Madrid 28668, Spain
[3] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain
关键词
BETA-SECRETASE INHIBITORS; ALZHEIMERS-DISEASE; CLEAVING ENZYME; REPLICA EXCHANGE; BINDING; HIT; GENERATION; PREDICTION; DYNAMICS; PROTEIN;
D O I
10.1021/acs.jcim.6b00220
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel spiroaminodihydropyrroles probing for optimized interactions at the P3 pocket of beta-secretase 1 (BACE1) were designed with the use of free energy perturbation (FEP) calculations. The resulting molecules showed pIC(50) potencies in enzymatic BACE1 inhibition assays ranging from approximately 5 to 7. Good correlation was observed between the predicted activity from the FEP calculations and experimental activity. Simulations run with a default 5 ns approach delivered a mean unsigned error (MUE) between prediction and experiment of 0.58 and 0.91 kcal/mol for retrospective and prospective applications, respectively. With longer simulations of 10 and 20 ns, the MUE was in both cases 0.57 kcal/mol for the retrospective application, and 0.69 and 0.59 kcal/mol for the prospective application. Other considerations that impact the quality of the Calculations are discussed. This work provides an example of the value of FEP as a computational tool for drug discovery.
引用
收藏
页码:1856 / 1871
页数:16
相关论文
共 50 条
  • [31] Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond
    Zhu, Zhaoning
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 233 - 240
  • [32] Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
    Green, Keith D.
    Fosso, Marina Y.
    Garneau-Tsodikova, Sylvie
    MOLECULES, 2018, 23 (12):
  • [33] Development of hydantoin spiropiperidines as potent BACE1 inhibitors
    Wai, Jenny M.
    Egbertson, Melissa
    Perlow, Debbie
    Coburn, Craig
    Neilson, Lou Anne
    Pitzenberger, Steve
    McGaughey, Georgia
    Colussi, Dennis
    Haugabook, Sharie
    Tugusheva, Katherine
    Chang, Jae
    Fandozzi, Christine
    Allison, Tim
    Dancho, Mandy
    Michener, Maria
    Posavec, Diane
    Pudvah, Nicole
    Vacca, Joe
    Graham, Sam
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [34] β-Secretase (BACE1) inhibitors from Sanguisorbae Radix
    Hee-Ju Lee
    Yeon-Hee Seong
    Ki-Hwan Bae
    Soon-Ho Kwon
    Hye-Min Kwak
    Si-Kab Nho
    Kyung-A Kim
    Jong-Moon Hur
    Kyung Bok Lee
    Young-Hwa Kang
    Kyung-Sik Song
    Archives of Pharmacal Research, 2005, 28 : 799 - 803
  • [35] Structure-Based β-Secretase (BACE1) Inhibitors
    Polgar, Timea
    Keseru, Gyoergy M.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (20) : 3373 - 3379
  • [36] 2-Iminohydantoins as potential BACE1 inhibitors
    Sun, Zhong-Yue
    Zhu, Zhaoning
    Ye, Yuanzan
    McKittrick, Brian
    Stamford, Andrew
    Wyss, Daniel
    Wang, Yu-Sen
    Senior, Mary
    Voigt, Johannes
    Strickland, Corey
    Madison, Vincent
    Kennedy, Matthew
    Kuvelkar, Reshma
    Chen, Xia
    Parker, Eric
    Hunter, John
    Czarniecki, Michael
    Greenlee, William
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [37] Pyridinyl aminohydantoins as small molecule BACE1 inhibitors
    Zhou, Ping
    Li, Yanfang
    Fan, Yi
    Wang, Zheng
    Chopra, Rajiv
    Olland, Andrea
    Hu, Yun
    Magolda, Ronald L.
    Pangalos, Menelas
    Reinhart, Peter H.
    Turner, M. James
    Bard, Jonathan
    Malamas, Michael S.
    Robichaud, Albert J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2326 - 2329
  • [38] Development of BACE1 inhibitors for Alzheimer's disease
    Guo, Tao
    Hobbs, Doug W.
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (15) : 1811 - 1829
  • [39] Carbazole-containing arylcarboxamides as BACE1 inhibitors
    Bertini, Simone
    Asso, Valentina
    Ghilardi, Elisa
    Granchi, Carlotta
    Manera, Clementina
    Minutolo, Filippo
    Saccomanni, Giuseppe
    Bortolato, Andrea
    Mason, Jonathan
    Moro, Stefano
    Macchia, Marco
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (22) : 6657 - 6661
  • [40] Synthetic Strategies of Nonpeptidic β-Secretase (BACE1) Inhibitors
    La Regina, Giuseppe
    Piscitelli, Francesco
    Silvestri, Romano
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2009, 46 (01) : 10 - 17